Hide on Homepage

UNIONDALE, N.Y., January 9, 2025 — The Lustgarten Foundation announced a new grant today, awarded to Nina Steele, PhD, and Howard Crawford, PhD, of the Henry Ford Pancreatic Cancer Center […]

On January 22, join us for an exclusive update as Lustgarten’s Vice President of Research, Andrew Rakeman, PhD, Chief Scientist David Tuveson, MD, PhD, and Chief Medical Advisor Elizabeth Jaffee, […]

Dr. David Slavin In September 2017, Dr. David Slavin, then a 54-year-old Chiropractor from Long Island, started experiencing stomach pain and just didn’t feel right, and he feared the worst. […]

It is with a heavy heart that we remember the life of valiant Lustgarten Foundation advocate, friend, and honorary chairman of our Corporate Advisory Board, President Jimmy Carter, 39th President […]

It is with profound sadness that we honor the life and legacy of Charles Dolan, Co-founder and Chairman Emeritus of the Lustgarten Foundation, following his passing on Saturday, December 28th, […]

Break Through Cancer has launched a collaborative cohort for a Phase 1 study of RMC-6236, a compound developed by Revolution Medicines that is designed to suppress multiple RAS proteins that […]

Learn how our LABS (Lustgarten Advancing Breakthrough Science) program fosters collaboration and accelerates breakthroughs in research from three of our six internationally renowned Lustgarten lab leaders — Tyler Jacks, PhD, […]

David Daniels In late 2021, David began experiencing pain in his upper abdomen that radiated to his back. Despite a colonoscopy and an upper endoscopy showing no abnormalities or disease, […]